Department of Pediatric Dermatology, Hôpital Necker-Enfants Malades (AP-HP), Paris, France.
J Am Acad Dermatol. 2012 Aug;67(2):233-9. doi: 10.1016/j.jaad.2011.08.008. Epub 2011 Oct 19.
Connective tissue nevi (CTN) may be isolated, either sporadic or hereditary, or syndromic as in the Buschke-Ollendorff syndrome. Few publications have addressed the variable clinical and histopathologic expression of these benign hamartomas.
We sought to characterize the clinical and histopathologic features of CTN and to highlight a spectrum of clinical disease.
We carried out a retrospective study of cases selected after strict clinical and histopathologic confirmation of the diagnosis.
A total of 33 patients with CTN were included. The average age of onset was 2 years. Three clinical forms were distinguished: type A with lesions at a single site, with one case presenting as an ulcerated infiltrated plaque; type B with two or more sites of involvement; and type C with unusually severe infiltration with functional impairment of a limb. Histopathologic examination of lesional biopsy specimens showed 10 collagenomas, one elastoma, 18 mixed CTN, and an increased number of fibroblasts in 4 cases. No correlation between clinical type and histopathologic findings was observed.
This was a descriptive case series.
CTN comprise a clinical spectrum ranging from isolated papules to unusually severe aggressive plaques with monomelic involvement. The histopathologic features are heterogeneous and include a newly described variant, which we name "cellular CTN" because of the increased number of fibroblasts.
结缔组织痣(CTN)可能是孤立的,散发或遗传性的,也可能是 Buschke-Ollendorff 综合征等综合征性的。少数出版物已经解决了这些良性错构瘤的可变临床和组织病理学表现。
我们旨在描述 CTN 的临床和组织病理学特征,并突出其临床疾病谱。
我们进行了一项回顾性研究,对经过严格的临床和组织病理学诊断确认的病例进行了选择。
共纳入 33 例 CTN 患者。发病的平均年龄为 2 岁。区分出三种临床形式:A 型病变位于单个部位,一例表现为溃疡性浸润性斑块;B 型有两个或更多部位受累;C 型为异常严重浸润,伴有肢体功能障碍。病变活检标本的组织病理学检查显示 10 例胶原瘤、1 例弹性瘤、18 例混合 CTN,4 例成纤维细胞数量增加。未观察到临床类型与组织病理学发现之间的相关性。
这是一项描述性病例系列研究。
CTN 构成了一个从孤立丘疹到异常严重侵袭性斑块的临床谱,伴有单肢受累。组织病理学特征是异质性的,包括一种新描述的变体,我们称之为“细胞性 CTN”,因为成纤维细胞数量增加。